<DOC>
	<DOCNO>NCT02378064</DOCNO>
	<brief_summary>The purpose study evaluate effect angiotensin receptor 1 blocker versus calcium channel blocker atherosclerotic plaque inflammation use serial FDG PET/CT image carotid artery .</brief_summary>
	<brief_title>Comparison Fimasartan Versus Amlodipine Therapy Carotid PlaquE Inflammation</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Plaque , Atherosclerotic</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe , Simvastatin Drug Combination</mesh_term>
	<criteria>Men Women least 18 year age inclusive Patients acute coronary syndrome unstable angina pectoris Hypertension blood pressure 140/90mmHg FDG PET/CT show least 1 hot uptake carotid ascend aorta The patient guardian agree study protocol schedule clinical FDG PET/CT followup , provide informed , write consent , approve appropriate Institutional Review Board/Ethical Committee respective clinical site . Patients treat carotid endarterectomy stent placement Chronic disease require treatment oral , intravenous , intraarticular corticosteroid ( use topical , inhaled , nasal corticosteroid permissible ) . Untreated hyperthyroidism , hypothyroidism Any clinically significant abnormality identify screen visit , physical examination , laboratory test , electrocardiogram , judgment Investigator , would preclude safe completion study . Evidence congestive heart failure , leave ventricular ejection fraction &lt; 40 % . Significant renal disease manifest serum creatinine &gt; 2.0mg/dL , creatinine clearance &lt; 40 ml/min ( CockcroftGault method ) . Hepatic disease biliary tract obstruction , significant hepatic enzyme elevation ( ALT AST &gt; 3 time upper limit normal ) . History adult asthma manifest bronchospasm past 6 month , currently take regular antiasthmatic medication ( ) . Unwillingness inability comply procedure describe protocol . Patient 's pregnant breastfeeding childbearing potential . Type I Diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Fluorodeoxyglucose F18</keyword>
	<keyword>Positron-Emission Tomography Computed Tomography</keyword>
	<keyword>Plaque , Atherosclerotic</keyword>
	<keyword>Renin-Angiotensin System</keyword>
</DOC>